Avoro Capital Advisors LLC - Significant Ownership

Signature - Title
Scott Epstein - Chief Compliance Officer & COO
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Avoro Capital Advisors LLC.

Significant Ownership of Avoro Capital Advisors LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
AADI Aadi Bioscience, Inc. Common stock, par value $0.0001 per share 19.99% $18.8M 11.9M BEHZAD AGHAZADEH Feb 28, 2025
ARWR Arrowhead Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 9.6% $181M 12M Avoro Capital Advisors LLC Dec 31, 2024
VERA Vera Therapeutics, Inc. Class A Common Stock, $0.001 par value per share 8.9% $159M 5.61M Avoro Capital Advisors LLC Dec 31, 2024
GLUE Monte Rosa Therapeutics, Inc. Common Stock, par value $0.0001 per share 7.1% $26.5M 4.35M Avoro Capital Advisors LLC Dec 31, 2024

Schedules 13D/G Reported by Avoro Capital Advisors LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.